SE

Senestech IncFRA Senestech Stock Report

Last reporting period 30 Jun, 2024

Updated —

Last price

Market cap $B

0.001

Micro

Exchange

XFRA - Deutsche Boerse AG

SE80.F Stock Analysis

SE

Uncovered

Senestech Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-1/100

Low score

Market cap $B

0.001

Dividend yield

Shares outstanding

2.107 B

SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations, primarily rat populations through fertility control. The company is headquartered in Flagstaff, Arizona. The company went IPO on 2016-12-08. Its product ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest limits the reproduction of male and female rats beginning with the first breeding cycle following consumption. ContraPest is a highly palatable liquid formulation that reduces fertility in both male and female rats. Its technology is effective on rat species and its technology can be applied to other mammalian species. ContraPest has two active ingredients: VCD and triptolide. Triptolide, derived from the thunder god vine Tripterygium wilfordii, used in traditional Chinese medicines and other over-the-counter supplements. Triptolide affects the reproductive capacity of both male and female rats. VCD is an occupational chemical that selectively destroys ovarian follicles in rats.

View Section: Eyestock Rating